Education
About Us
Working with TipRanks
Follow Us
ClearPoint Neuro (CLPT)
NASDAQ:CLPT
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.16Last Year’s EPS
-0.16Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 26, 2025
|% Change Since: -21.31%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Positive
ClearPoint Neuro demonstrated strong financial performance with significant revenue growth across various segments and improved gross margins. The company launched several new products and achieved a debt-free status, indicating positive strategic progress. However, there were challenges with a decrease in cash position and increased operating expenses, which slightly dampen the overall positive outlook.Company Guidance
During the call, ClearPoint Neuro, Inc. provided guidance for 2025, emphasizing their transition into the "Fast. Forward" phase. The company anticipates total revenue for 2025 to be between $36 million and $41 million, representing a growth of 15% to 31% compared to 2024. In 2024, total revenues were $31.4 million, a 31% increase from $24 million in 2023. The revenue was split into biologics and drug delivery, neurosurgery navigation therapy, and capital equipment and software. Biologics and drug delivery revenue saw a 27% increase, while neurosurgery navigation revenue grew by 21%. Capital equipment and software revenue experienced a significant 107% increase. The company's gross margin improved to 61% from 57% in 2023. Research and development costs increased by 6%, and sales and marketing expenses rose by 15%, while general and administrative expenses saw a slight 2% increase. ClearPoint's operational cash burn decreased by 35%, with cash and cash equivalents standing at $20.1 million at the end of 2024. The company aims to extend its lead in cell and gene therapy delivery, evolve its product portfolio, and expand its global installed base, targeting the approval of additional therapies within the next two years.Record Revenue Growth
ClearPoint Neuro reported total revenues of $31.4 million for the year ended December 31, 2024, representing a 31% increase over the previous year's revenue of $24 million.
Strong Biologics and Drug Delivery Growth
Biologics and drug delivery revenue increased by 27% to $17.3 million in 2024, driven by an increase in product sales as pharmaceutical partners advanced their development programs.
Capital Equipment and Software Surge
Capital equipment and software revenue grew 107% to $3.8 million for the year 2024, indicating significant expansion of the installed base.
Improved Gross Margin
Gross margin for the full year 2024 was 61%, up from 57% in 2023, primarily due to lower costs from transitioning to a new manufacturing facility and higher volumes.
Successful New Product Launches
Successfully launched new MR navigation systems, operating room navigation systems, drug delivery technologies, laser therapy and access products, and preclinical and clinical drug discovery services.
Debt-Free Status Achieved
Completed an equity offering with net proceeds of $16.2 million, allowing the company to retire all outstanding debt and end 2024 debt-free.
---
CLPT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CLPT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 26, 2025 | $17.22 | $14.20 | -17.54% |
| Nov 07, 2024 | $13.42 | $11.65 | -13.19% |
| Aug 07, 2024 | $6.44 | $9.06 | +40.68% |
| May 07, 2024 | $5.89 | $5.99 | +1.70% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does ClearPoint Neuro (CLPT) report earnings?
ClearPoint Neuro (CLPT) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is ClearPoint Neuro (CLPT) earnings time?
ClearPoint Neuro (CLPT) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CLPT EPS forecast?
CLPT EPS forecast for the fiscal quarter 2025 (Q1) is -0.16.
---